Table 1 Baseline characteristics
Characteristics | Baseline |
|---|---|
No. of patients | 24 |
Sex (males/females) | 5/19 |
Age (y) | 44 ± 12 |
BMI | 28.3 ± 4.9 |
FeNO (ppb) | 17.8 (12.6; 45.6) |
Total serum IgE (kU/L) | 67 (14; 219) |
Blood eosinophil count (109/L) | 0.15 (0.06; 0.29) |
ACQ score | 2.64 ± 0.60 |
AQLQ score | 4.15 ± 0.96 |
Dose of LABA (μg/d salmeterol equivalents) | 135 ± 55 |
Dose of ICS (μg/d fluticasone equivalents) | 1174 ± 508 |
No. of patients on maintenance use of OCS | 7 |
Dose of oral prednisone (mg/d) | 12 ± 6 |
No. of patients on omalizumab | 3 |